Trupanion (TRUP) Rating Reiterated by Cowen

Trupanion (TRUP) Rating Reiterated by Cowen

Cowen restated their outperform rating on shares of Trupanion (NASDAQ:TRUP) in a report published on Wednesday morning, The Fly reports. Cowen currently has a $38.00 target price on the financial services provider’s stock, up from their prior target price of $32.00.

A number of other equities research analysts also recently commented on TRUP. Northland Securities reissued a buy rating and issued a $38.00 target price on shares of Trupanion in a report on Thursday, February 8th. Zacks Investment Research downgraded Trupanion from a buy rating to a hold rating in a report on Tuesday, October 17th. BidaskClub downgraded Trupanion from a buy rating to a hold rating in a report on Friday, November 10th. Stifel Nicolaus reissued a buy rating and issued a $34.00 target price (up previously from $33.00) on shares of Trupanion in a report on Wednesday. Finally, Canaccord Genuity reissued a buy rating and issued a $35.00 target price (up previously from $29.00) on shares of Trupanion in a report on Tuesday, October 31st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of Buy and an average price target of $35.57.

Shares of Trupanion (NASDAQ TRUP) opened at $28.29 on Wednesday. The company has a current ratio of 1.89, a quick ratio of 1.87 and a debt-to-equity ratio of 0.19. Trupanion has a fifty-two week low of $13.88 and a fifty-two week high of $36.88. The firm has a market capitalization of $894.21, a price-to-earnings ratio of -471.42 and a beta of 0.34.

Trupanion (NASDAQ:TRUP) last released its earnings results on Tuesday, February 13th. The financial services provider reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.03). Trupanion had a negative net margin of 0.62% and a negative return on equity of 6.66%. The business had revenue of $66.55 million during the quarter, compared to analyst estimates of $65.60 million. analysts anticipate that Trupanion will post 0.01 EPS for the current year.

In other news, insider Darryl Rawlings sold 3,500 shares of Trupanion stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $34.36, for a total transaction of $120,260.00. Following the completion of the transaction, the insider now owns 1,382,976 shares of the company’s stock, valued at approximately $47,519,055.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO Ian Moffat sold 7,000 shares of Trupanion stock in a transaction on Monday, November 27th. The stock was sold at an average price of $30.06, for a total value of $210,420.00. Following the transaction, the chief operating officer now directly owns 7,000 shares of the company’s stock, valued at approximately $210,420. The disclosure for this sale can be found here. In the last three months, insiders sold 25,039 shares of company stock valued at $775,403. 31.24% of the stock is owned by corporate insiders.

Several large investors have recently added to or reduced their stakes in the company. Nine Ten Capital Management LLC raised its stake in shares of Trupanion by 0.7% during the 4th quarter. Nine Ten Capital Management LLC now owns 1,384,867 shares of the financial services provider’s stock worth $40,535,000 after buying an additional 9,900 shares during the last quarter. BlackRock Inc. raised its stake in shares of Trupanion by 15.2% during the 4th quarter. BlackRock Inc. now owns 1,310,881 shares of the financial services provider’s stock worth $38,370,000 after buying an additional 172,785 shares during the last quarter. Baillie Gifford & Co. raised its stake in shares of Trupanion by 2.4% during the 3rd quarter. Baillie Gifford & Co. now owns 1,005,983 shares of the financial services provider’s stock worth $26,568,000 after buying an additional 23,610 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Trupanion by 16.6% during the 2nd quarter. Vanguard Group Inc. now owns 758,594 shares of the financial services provider’s stock worth $16,977,000 after buying an additional 108,135 shares during the last quarter. Finally, Renaissance Technologies LLC raised its stake in shares of Trupanion by 3.0% during the 4th quarter. Renaissance Technologies LLC now owns 392,900 shares of the financial services provider’s stock worth $11,500,000 after buying an additional 11,616 shares during the last quarter. 63.79% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This story was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/02/18/trupanion-trup-rating-reiterated-by-cowen.html.

About Trupanion

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

The Fly

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.

Cowen reiterated their outperform rating on shares of Trupanion (NASDAQ:TRUP) in a report published on Wednesday, The Fly reports. The firm currently has a $38.00 price target on the financial services provider’s stock, up from their prior price target of $32.00.

Other equities analysts have also issued reports about the stock. Zacks Investment Research upgraded shares of Trupanion from a hold rating to a buy rating and set a $37.00 target price on the stock in a research report on Wednesday, November 8th. Canaccord Genuity restated a buy rating and set a $35.00 target price (up from $29.00) on shares of Trupanion in a research report on Tuesday, October 31st. Stifel Nicolaus restated a buy rating and set a $34.00 target price (up from $33.00) on shares of Trupanion in a research report on Wednesday. Northland Securities restated a buy rating and set a $38.00 target price on shares of Trupanion in a research report on Thursday, February 8th. Finally, BidaskClub upgraded shares of Trupanion from a hold rating to a buy rating in a research report on Monday, December 18th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. Trupanion presently has a consensus rating of Buy and an average price target of $35.57.

Trupanion (NASDAQ TRUP) opened at $28.29 on Wednesday. The company has a market cap of $894.21, a P/E ratio of -471.42 and a beta of 0.34. Trupanion has a one year low of $13.88 and a one year high of $36.88. The company has a quick ratio of 1.87, a current ratio of 1.89 and a debt-to-equity ratio of 0.19.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Tuesday, February 13th. The financial services provider reported ($0.05) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.02) by ($0.03). The company had revenue of $66.55 million during the quarter, compared to analysts’ expectations of $65.60 million. Trupanion had a negative net margin of 0.62% and a negative return on equity of 6.66%. equities research analysts anticipate that Trupanion will post 0.01 EPS for the current fiscal year.

In other news, insider Asher Bearman sold 4,039 shares of the firm’s stock in a transaction that occurred on Tuesday, November 21st. The shares were sold at an average price of $28.40, for a total transaction of $114,707.60. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Ian Moffat sold 7,000 shares of the stock in a transaction on Monday, November 27th. The stock was sold at an average price of $30.06, for a total value of $210,420.00. Following the sale, the chief operating officer now directly owns 7,000 shares of the company’s stock, valued at $210,420. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 25,039 shares of company stock worth $775,403. Insiders own 31.24% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. MetLife Investment Advisors LLC acquired a new stake in shares of Trupanion during the fourth quarter worth $324,000. PEAK6 Investments L.P. acquired a new stake in shares of Trupanion during the fourth quarter worth $289,000. Millennium Management LLC acquired a new stake in shares of Trupanion during the fourth quarter worth $6,851,000. Nine Ten Capital Management LLC lifted its holdings in shares of Trupanion by 0.7% during the fourth quarter. Nine Ten Capital Management LLC now owns 1,384,867 shares of the financial services provider’s stock worth $40,535,000 after purchasing an additional 9,900 shares during the period. Finally, Two Sigma Investments LP lifted its holdings in shares of Trupanion by 63.1% during the fourth quarter. Two Sigma Investments LP now owns 200,552 shares of the financial services provider’s stock worth $5,870,000 after purchasing an additional 77,567 shares during the period. 63.79% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Trupanion (TRUP) Rating Reiterated by Cowen” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/02/18/trupanion-trup-rating-reiterated-by-cowen.html.

About Trupanion

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

The Fly

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply